This page includes the latest FDA filings for Chiasma Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | CHMA | DUNS 024497244 |
Device Company | Device | Date |
---|---|---|
Amryt Pharmaceuticals Designated Activity Company, Almac Pharma Services Limited, Lyophilization Services of New England, Inc. (LSNE), MW ENCAP LIMITED | Prescription Medication | 2023-09-16 |
Amryt Pharmaceuticals Designated Activity Company, Almac Pharma Services Limited, Lyophilization Services of New England, Inc. (LSNE), MW ENCAP LIMITED | Prescription Medication | 2022-12-11 |
Amryt Pharmaceuticals Designated Activity Company, Almac Pharma Services Limited, Lyophilization Services of New England, Inc. (LSNE), MW ENCAP LIMITED | Prescription Medication | 2020-12-24 |
Amryt Pharmaceuticals Designated Activity Company, Almac Pharma Services Limited, Lyophilization Services of New England, Inc. (LSNE), MW ENCAP LIMITED | Prescription Medication | 2020-07-31 |
Amryt Pharmaceuticals Designated Activity Company, Almac Pharma Services Limited, Lyophilization Services of New England, Inc. (LSNE), MW ENCAP LIMITED | Prescription Medication | 2020-07-08 |
Chiasma Inc. | Mycapssa | 2020-07-06 |
CHIASMA INC | 2020-06-30 22:19:49 |
NCAGE Code | 8Q9K1 | CHIASMA, INC. |
SEC | 0001339469 | CHIASMA, INC of DELAWARE |